In this context we measured FGF23 levels in patients with end-stage liver disease on a liver transplantation waiting list and found that FGF23 concentration was increased even in the absence of renal insufficiency and was associated with the risk of death on the waiting list. The gene discussed is FGF23; the disease is Renal insufficiency.